OraSure Technologies Inc. (NASDAQ:OSUR) had a loss and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 0.84%.
OraSure Technologies Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased to $-0.18 in the quarter versus EPS of $-0.07 in the year-earlier quarter.
Revenue: Rose 1.24% to $21.2 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: OraSure Technologies Inc. reported adjusted EPS loss of $0.18 per share. By that measure, the company met the mean analyst estimate of $-0.18. It beat the average revenue estimate of $20.82 million.
Quoting Management: “We are pleased to see the first quarter performance by our molecular collection systems business and the increasing sales of our OraQuick(NYSE:R) In-Home HIV test,” said Douglas A. Michels, President and Chief Executive Officer of OraSure Technologies, Inc. “We continue to refine our advertising and promotion strategies as we learn more about how consumers are responding to the availability of our In-Home HIV test.”
Key Stats (on next page)…